NewsSTAT
Ranked by formulaVerdict: RoutineSTAT+: On Wall Street, there's trouble stirring for biotech
On Wall Street, the real trouble for biotech, and the reason for investor angst, lies below the surface.
Score█████░░░░░4.9
VerdictCompetent work. Briefs at most.
Summary from the source
On Wall Street, the real trouble for biotech, and the reason for investor angst, lies below the surface.
The editor's rubric
| Dimension | Level | Weight | What that level means |
|---|---|---|---|
| Leverage | ██░░░ 2 | 15% | Reusable within one subfield (a technique, dataset, or protocol a few groups will adopt). |
| Magnitude | ██░░░ 2 | 20% | Solid incremental gain on a meaningful problem. |
| Evidence | ██░░░ 2 | 20% | Limited: single setting, weak baselines, or an observational association presented as causal. |
| Novelty | ██░░░ 2 | 10% | A new combination of known ideas. |
| Trajectory | ██░░░ 2 | 10% | Some room to improve with obvious engineering. |
| Stakes | ██░░░ 2 | 25% | Benefits a professional community (practitioners, clinicians, engineers). |
Editor’s rationale
Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: verification (error bars).
How the score was computed
Score█████░░░░░4.9
- Merit
- 3.4 / 10
- Adjusted merit
- 3.8 / 10
- Attention
- 28%
- Freshness
- 91%